GD2-specific Chimeric Antigen Receptor-modified T Cells for the treatment of Refractory and/or Recurrent Neuroblastoma in Pediatric Patients
Lihua Yu(Zhujiang Hospital), Lihua Yang(Kunming Medical University), Guanmei Zhang(Zhujiang Hospital), Lulu Huang(Royal Netherlands Academy of Arts and Sciences), Lichan Liang(Zhujiang Hospital), Yinghua Zeng(Nanfang Hospital), Danna Lin(Zhujiang Hospital), Bin Wang(Zhujiang Hospital), Yuchen Liu(Fudan University), Jiale Liu(Zhujiang Hospital), Shaohua Tao(Zhujiang Hospital), Cheng Jiao(Shenzhen Genoimmune Medical Institute), Xu Liao(Zhujiang Hospital), Xiaorong Lai(Zhujiang Hospital), Lung‐Ji Chang(University of Florida), Li Wu(Zhujiang Hospital), Wu Zhu(Zhujiang Hospital)
Cited by 7
Related Papers
Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells
|Nature Communications|2014|225
Derivation and large-scale expansion of multipotent astroglial neural progenitors from adult human brain
|Development|2006|112
Chiral kinetic theory in curved spacetime
|Physical review. D/Physical review. D.|2019|94
GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients
|Journal of Cancer Research and Clinical Oncology|2021|84